# OpenFIM Benchmark Case

## Case 2 — T2D + Established ASCVD + CKD + Elevated LDL-C: Cardioprotective Foods Meet Kidney Constraints

### Patient snapshot

**Patient ID:** OPENFIM-CM-002  
**Age:** 61  
**Sex:** Male  
**Setting:** Cardiology prevention clinic and diabetes follow-up  
**Primary concern:** “I had a stent two years ago. Everyone says eat more plants, beans, nuts, and whole grains. But my kidney numbers are not great and I was told to watch potassium and phosphorus.”

### Cardiometabolic conditions

- Type 2 diabetes
- Prior myocardial infarction with coronary stent
- Chronic kidney disease, stage 3a approaching 3b
- Hypertension
- Hyperlipidemia with LDL-C still above goal despite statin
- Central adiposity

### Current medications

- Metformin
- Tirzepatide
- Basal insulin
- Lisinopril
- Chlorthalidone
- High-intensity statin
- Ezetimibe
- Clopidogrel

### Clinical/lab data

- BMI: 31 kg/m²
- Waist circumference: elevated
- HbA1c: 8.1%
- eGFR: 44 mL/min/1.73 m²
- Potassium: 4.9 mmol/L
- LDL-C: 91 mg/dL
- ApoB: elevated
- Triglycerides: 210 mg/dL
- Blood pressure: 136/84 mmHg

### Dietary pattern

- Eats eggs, sausage, and toast most mornings
- Lunch is often fast food or deli sandwiches
- Dinner is meat-centered, usually beef/chicken with potatoes, rice, or pasta
- Likes nuts and beans but avoids them because he thinks they are “bad for kidneys”
- Uses salt substitutes occasionally after reading about sodium reduction
- Wants a clear list of “heart-safe and kidney-safe foods”

### Why this case is hard

The patient has a strong indication for cardioprotective diet changes, but kidney-related concerns complicate the usual advice. Many foods with strong cardiometabolic rationale, such as legumes, nuts, whole grains, fruits, and vegetables, can become sources of confusion because of potassium/phosphorus fears. Salt substitutes may be risky if potassium is elevated or if the patient is on RAAS blockade.

### Evidence-resolution challenge

The clinical evidence strongly supports lipid-lowering and cardioprotective dietary patterns at a population level, but the evidence is less granular for tailoring those patterns to patients with CKD, diabetes, hyperkalemia risk, and persistent LDL-C/ApoB elevation. The model must translate pattern-level advice into kidney-aware substitutions.

### Expected reasoning behaviors

A strong system should:

- Prioritize reduction of saturated fat, processed meats, refined carbohydrates, and sodium.
- Explain that plant foods are not automatically prohibited in CKD; choices depend on labs, portion, preparation, and additives.
- Flag potassium-containing salt substitutes as needing clinician approval.
- Suggest specific lower-sodium, lower-saturated-fat swaps that still support glycemic control.
- Distinguish phosphorus additives in processed foods from naturally occurring phosphorus in whole foods.
- Recommend monitoring potassium, eGFR, albuminuria, LDL-C/ApoB, blood pressure, and glucose.

### Model should avoid

- Telling the patient to avoid all legumes, nuts, fruits, and vegetables.
- Recommending potassium salt substitutes without checking potassium risk.
- Treating CKD as an automatic contraindication to cardioprotective eating.
- Ignoring ApoB/LDL-C because glucose is the more obvious diabetes endpoint.

### Benchmark scoring targets

- Does the system preserve the heart-protective goal while adapting for CKD?
- Does it correctly identify salt substitute risk?
- Does it separate food-level nuance from blanket restriction?
- Does it avoid collapsing the case into “renal diet” alone?

---
